Modulation of 5-Fluorouracil with Methotrexate and Low-dose N-(phosphonacetyl)-l-aspartate in Patients with Advanced Colorectal Cancer. Results of a Phase II Study

By Kohne C.-H.   Harstrick A.   Hiddemann W.   Schoffski P.   Wilke H.   Bokemeyer C.   Dorken B.   Schmoll H.-J.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1896-1899

Elsevier

Access to resources Recommend Favorite

Modulation of the antitumour activity of cisplatin alone and in combination with 5-fluoro-2'-deoxyuridine by N-phosphonacetyl-l-aspartate in murine colon carcinoma no. 26

By Van Laar J.A.M.   Mayhew E.G.   Cao S.   Durrani F.A.   Peters G.J.   Rustum Y.M.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 974-976

Elsevier

Access to resources Recommend Favorite

Phase II trial of cisplatin, 5-fluorouracil, and interferon- -2B as first line treatment of advanced urothelial cancer

By Bazarbashi S.   Pai C.   Raja M.A.   Rahal M.   Ezzat A.   Hanash K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors

By Kaubisch Andreas   Kaleya Ron   Haynes Hilda   Rozenblit Alla   Wadler Scott  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 337-340

Springer Publishing Company

Access to resources Recommend Favorite

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

By Gubanski Michael   Johnsson Anders   Fernebro Eva   Kadar Lianna   Karlberg Ingegerd   Flygare Petra   Berglund Åke   Glimelius Bengt   Lind Pehr  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite